Chlorogenic Acid API Companies and Future Market Positioning

Top Vendors in the Chlorogenic Acid API Market & Their Offering with Recent Updates

Naturex (Givaudan)

Headquarters: Avignon, France
Offerings: Standardized green coffee bean extracts rich in chlorogenic acid for pharmaceutical, nutraceutical, and functional food applications, with a strong focus on traceability and quality compliance.

Euromed S.A.

Headquarters: Barcelona, Spain
Offerings: High-purity botanical extracts, including chlorogenic acid–rich plant extracts, tailored for pharmaceutical APIs, dietary supplements, and clinical-grade nutraceutical formulations.

Applied Food Sciences (AFS)

Headquarters: Texas, USA
Offerings: Branded green coffee bean extracts with defined chlorogenic acid content, primarily serving dietary supplements, weight-management, and metabolic health formulations.

Sabinsa Corporation

Headquarters: New Jersey, USA
Offerings: Science-backed herbal and botanical APIs, including chlorogenic acid extracts, supported by clinical validation for pharmaceutical, nutraceutical, and preventive healthcare products.

Zhejiang Skyherb Biotechnology

Headquarters: Zhejiang, China
Offerings: Cost-effective chlorogenic acid and green coffee bean extracts at multiple purity levels, supplying bulk APIs to pharmaceutical, nutraceutical, and functional food manufacturers globally.

Indfrag Bioscience

Headquarters: Bengaluru, India
Offerings: Natural plant-based extracts and APIs, including chlorogenic acid ingredients, focused on pharmaceutical-grade quality, sustainability, and global export markets.

Value Chain Analysis

R&D

• Research and development activities for chlorogenic acid (CGA) APIs are accelerating, supported by biotechnological progress, rising demand for plant-based therapeutics, and the need for high-purity pharmaceutical ingredients. The focus is shifting toward sustainable, high-yield extraction technologies and improved stability profiles to enhance therapeutic use.
• Key players: Naturex (Givaudan), Sabinsa Corporation, Chengdu Wagott Bio-Tech, Naturextra, and Xi’an Lyphar Biotech.

Formulation

• Chlorogenic acid (CGA) APIs are increasingly formulated with advanced drug-delivery systems to improve poor bioavailability, with nanostructured lipid carriers (NLCs) showing strong effectiveness. Typical optimized formulations use lipid matrices such as stearic and oleic acids, Poloxamer 188 as a stabilizing surfactant, and low-dose CGA API to enhance absorption, stability, and therapeutic performance.
• Key players: Indena S.p.A., Bio-Botanica Inc., Cayman Chemical, Merck KGaA, and Layn Natural Ingredients.

Distribution

• The distribution of chlorogenic acid (CGA) APIs is supported by rising global demand for natural antioxidant ingredients. These APIs are mainly derived from green coffee beans, honeysuckle, and Eucommia bark, with a strong focus on 98% high-purity grades. Supply channels include direct manufacturer sales, distributors, and digital platforms, serving pharmaceutical, nutraceutical, and food enrichment applications.
• Key players: TCI Chemicals, Extrasynthese, Tokyo Chemical Industry, Shaanxi Sciphar Hi-Tech, and Nutra Green Biotechnology.

Market Growth

The global chlorogenic acid API market size was estimated at USD 150 million in 2025 and is predicted to increase from USD 154.58 million in 2026 to approximately USD 202.57 million by 2035, expanding at a CAGR of 3.05% from 2026 to 2035.

What are the Recent Developments in the Chlorogenic Acid API Market?

• In September 2025, studies identified hepatoprotective effects of chlorogenic acid in promoting liver regeneration after acetaminophen-induced injury via antioxidant mechanisms, suggesting expanded therapeutic potential beyond traditional antioxidant uses.
• In March 2025, researchers developed a chemiluminescent enzyme immunoassay (CLEIA) for accurate and sensitive measurement of chlorogenic acid in pharmaceutical products, improving quality control and detection capabilities. This method enhances precision over traditional HPLC techniques.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com